BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25607438)

  • 1. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Pinsky PF
    N Engl J Med; 2015 Jan; 372(4):387. PubMed ID: 25607438
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Tierney WM
    N Engl J Med; 2015 Jan; 372(4):387-8. PubMed ID: 25607439
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Keeler EB; Soneji SS
    N Engl J Med; 2015 Jan; 372(4):388. PubMed ID: 25607437
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer CT screening is cost-effective but implementation matters.
    Goulart B
    Evid Based Med; 2015 Apr; 20(2):78. PubMed ID: 25715973
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of CT screening in the National Lung Screening Trial.
    Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
    N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.
    Kumar V; Cohen JT; van Klaveren D; Soeteman DI; Wong JB; Neumann PJ; Kent DM
    Ann Intern Med; 2018 Feb; 168(3):161-169. PubMed ID: 29297005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
    Tomonaga Y; Ten Haaf K; Frauenfelder T; Kohler M; Kouyos RD; Shilaih M; Lorez M; de Koning HJ; Schwenkglenks M; Puhan MA
    Lung Cancer; 2018 Jul; 121():61-69. PubMed ID: 29858029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care perspective on lung cancer screening.
    Leventhal W
    J Thorac Imaging; 2012 Jul; 27(4):209-10. PubMed ID: 22847587
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost effectiveness of chest CT in T1N0M0 lung cancer.
    Black WC; Armstrong P; Daniel TM
    Radiology; 1988 May; 167(2):373-8. PubMed ID: 3128840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
    Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
    Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
    Puggina A; Broumas A; Ricciardi W; Boccia S
    Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic impact of lung cancer screening in France: A modeling study].
    Gendarme S; Perrot É; Reskot F; Bhoowabul V; Fourre G; Souquet PJ; Milleron B; Couraud S
    Rev Mal Respir; 2017 Sep; 34(7):717-728. PubMed ID: 26585377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for lung cancer using CT: time for implementation?].
    de Jong PA; Lammers JW
    Ned Tijdschr Geneeskd; 2013; 157(46):A7019. PubMed ID: 24220184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer screening: examining the issues.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS1-6. PubMed ID: 22614958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.